OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma
Shlomit Kfir‐Erenfeld, Nathalie Asherie, Eyal Lebel, et al.
Blood Advances (2024) Vol. 8, Iss. 15, pp. 4077-4088
Closed Access | Times Cited: 4
Shlomit Kfir‐Erenfeld, Nathalie Asherie, Eyal Lebel, et al.
Blood Advances (2024) Vol. 8, Iss. 15, pp. 4077-4088
Closed Access | Times Cited: 4
Showing 4 citing articles:
Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study
Maximilian Merz, Anca‐Maria Albici, Bastian von Tresckow, et al.
HemaSphere (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Maximilian Merz, Anca‐Maria Albici, Bastian von Tresckow, et al.
HemaSphere (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Unveiling causal immune cell–gene associations in multiple myeloma: insights from systematic reviews and Mendelian randomization analyses
Hui Zhang, Ling Zhang, Jing-Xuan Lian, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Hui Zhang, Ling Zhang, Jing-Xuan Lian, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Efficacy and Safety of Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor T-Cell for the Treatment of Relapsed and Refractory AL Amyloidosis
Eyal Lebel, Nathalie Asherie, Shlomit Kfir‐Erenfeld, et al.
Journal of Clinical Oncology (2024)
Closed Access | Times Cited: 1
Eyal Lebel, Nathalie Asherie, Shlomit Kfir‐Erenfeld, et al.
Journal of Clinical Oncology (2024)
Closed Access | Times Cited: 1
Comparison of CAR T-cell and bispecific antibody as third-line or later-line treatments for multiple myeloma: a meta-analysis
Xiaojie Liang, Yufan Wang, Baiwei Luo, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e010064-e010064
Open Access
Xiaojie Liang, Yufan Wang, Baiwei Luo, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e010064-e010064
Open Access
